Chapter 59 Approaches to neuroprotective and reperfusion injury therapy

Handbook of Clinical Neurology

Volumn 94, Issue , 2008, Pages 1205-1223

  Papadakis, Michalis ^a   Buchan, Alastair ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 66049157391     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0072-9752(08)94059-8     Document Type: Review

References (130)

1. Aarts M., Liu Y., Liu L., et al. Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions. Science 298 (2002) 846-850
2. Aarts M., Iihara K., Wei W.L., et al. A key role for TRPM7 channels in anoxic neuronal death. Cell 115 (2003) 863-877
3. Adams Jr. H.P., Brott T.G., Furlan A.J., et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Stroke 27 (1996) 1711-1718
4. Allan S.M., Tyrrell P.J., and Rothwell N.J. Interleukin-1 and neuronal injury. Nat Rev Immunol 5 (2005) 629-640
5. Altman D.G., Schulz K.F., Moher D., et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 134 (2001) 663-694
6. Amin-Hanjani S., Stagliano N.E., Yamada M., et al. Mevastatin, an HMG-coA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke 32 (2001) 980-986
7. Arundine M., and Tymianski M. Molecular mechanisms of calcium-dependent neurodegeneration in excitotoxicity. Cell Calcium 34 (2003) 325-337
8. 2+ exchanger in excitotoxicity. Cell 120 (2005) 275-285
9. Barber P.A., Hoyte L., Colbourne F., et al. Temperature-regulated model of focal ischemia in the mouse: a study with histopathological and behavioral outcomes. Stroke 35 (2004) 1720-1725
10. Barber P.A., Foniok T., Kirk D., et al. MR molecular imaging of early endothelial activation in focal ischemia. Ann Neurol 56 (2004) 116-120
11. Benveniste H., Drejer J., Schousboe A., et al. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microdialysis. J Neurochem 43 (1984) 1369-1374
12. Bernard S.A., Gray T.W., Buist M.D., et al. Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 346 (2002) 557-563
13. Berti R., Williams A.J., Velarde L.C., et al. Effect of the proteasome inhibitor MLN519 on the expression of inflammatory molecules following middle cerebral artery occlusion and reperfusion in the rat. Neurotox Res 5 (2003) 505-514
14. Bigelow W.G., Lindsay W.K., and Greenwod W.F. Hypothermia; its possible role in cardiac surgery: an investigation of factors governing survival in dogs at low body temperatures. Ann Surg 132 (1950) 849-866
15. Boast C.A., Gerhardt S.C., Pastor G., et al. The N-methyl-D-aspartate antagonists CGS 19755 and CPP reduce ischemic brain damage in gerbils. Brain Res 442 (1988) 345-348
16. Boutin H., LeFeuvre R.A., Horai R., et al. Role of IL-1alpha and IL-1beta in ischemic brain damage. J Neurosci 21 (2001) 5528-5534
17. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 36 (2000) 970-1062
18. Bruhn T., Levy L.M., Nielsen M., et al. Ischemia induced changes in expression of the astrocyte glutamate transporter GLT1 in hippocampus of the rat. Neurochem Int 37 (2000) 277-285
19. Bruno V., Battaglia G., Copani A., et al. Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs. J Cereb Blood Flow Metab 21 (2001) 1013-1033
20. Buchan A., and Pulsinelli W.A. Hypothermia but not the N-methyl-D-aspartate antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia. J Neurosci 10 (1990) 311-316
21. Buchan A.M., Li H., Cho S., et al. Blockade of the AMPA receptor prevents CA1 hippocampal injury following severe but transient forebrain ischemia in adult rats. Neurosci Lett 132 (1991) 255-258
22. Buchan A., Li H., and Pulsinelli W.A. The N-methyl-D-aspartate antagonist, MK-801, fails to protect against neuronal damage caused by transient, severe forebrain ischemia in adult rats. J Neurosci 11 (1991) 1049-1056
23. Buchan A.M., Xue D., and Slivka A. A new model of temporary focal neocortical ischemia in the rat. Stroke 23 (1992) 273-279
24. Buchan A.M., Slivka A., and Xue D. The effect of the NMDA receptor antagonist MK-801 on cerebral blood flow and infarct volume in experimental focal stroke. Brain Res 574 (1992) 171-177
25. Cerami A., Brines M.L., Ghezzi P., et al. Effects of epoetin alfa on the central nervous system. Semin Oncol 28 (2001) 66-70
26. Chan P.H. Future targets and cascades for neuroprotective strategies. Stroke 35 (2004) 2748-2750
27. Choi D.W. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neurosci Lett 58 (1985) 293-297
28. Choi D.W. Ionic dependence of glutamate neurotoxicity. J Neurosci 7 (1987) 369-379
29. Choi D.W. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 18 (1995) 58-60
30. Choi D.W., Viseskul V., Amirthanayagam M., et al. Aspartate neurotoxicity on cultured cortical neurons. J Neurosci Res 23 (1989) 116-121
31. Clark G.D., and Rothman S.M. Blockade of excitatory amino acid receptors protects anoxic hippocampal slices. Neuroscience 21 (1987) 665-671
32. Colbourne F., Li H., Buchan A.M., et al. Continuing postischemic neuronal death in CA1: influence of ischemia duration and cytoprotective doses of NBQX and SNX-111 in rats. Stroke 30 (1999) 662-668
33. Colbourne F., Li H., and Buchan A.M. Indefatigable CA1 sector neuroprotection with mild hypothermia induced 6 hours after severe forebrain ischemia in rats. J Cereb Blood Flow Metab 19 (1999) 742-749
34. Colbourne F., Corbett D., Zhao Z., et al. Prolonged but delayed postischemic hypothermia: a long-term outcome study in the rat middle cerebral artery occlusion model. J Cereb Blood Flow Metab 20 (2000) 1702-1708
35. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J 341 (1999) 233-249
36. Daimon M., Aomi S., Kawamata T., et al. Pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, reduces delayed neuronal death following transient forebrain ischemia in the adult rat hippocampus. Neurosci Lett 362 (2004) 122-126
37. Davis S.M., Albers G.W., Diener H.C., et al. Termination of acute stroke studies involving selfotel treatment. ASSIST steering committed. Lancet 349 (1997) 32
38. Dawson V.L., Dawson T.M., London E.D., et al. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 88 (1991) 6368-6371
39. De Giorgi F., Lartigue L., Bauer M.K., et al. The permeability transition pore signals apoptosis by directing Bax translocation and multimerization. FASEB J 16 (2002) 607-609
40. Di Napoli M., and Papa F. NCX-4016 nicox. Curr Opin Investig Drugs 4 (2003) 1126-1139
41. Drejer J., Benveniste H., Diemer N.H., et al. Cellular origin of ischemia-induced glutamate release from brain tissue in vivo and in vitro. J Neurochem 45 (1985) 145-151
42. Dringen R., Gebhardt R., and Hamprecht B. Glycogen in astrocytes: possible function as lactate supply for neighboring cells. Brain Res 623 (1993) 208-214
43. Drukarch B., Schepens E., Stoof J.C., et al. Anethole dithiolethione prevents oxidative damage in glutathione-depleted astrocytes. Eur J Pharmacol 329 (1997) 259-262
44. Ehrenreich H., Hasselblatt M., Dembowski C., et al. Erythropoietin therapy for acute stroke is both safe and beneficial. Mol Med 8 (2002) 495-505
45. Elliott P.J., Zollner T.M., and Boehncke W.H. Proteasome inhibition: a new anti-inflammatory strategy. J Mol Med 81 (2003) 235-245
46. Emsley H.C., Smith C.J., Georgiou R.F., et al. A randomised phase II study of interleukin-1 receptor antagonist in acute stroke patients. J Neurol Neurosurg Psychiatry 76 (2005) 1366-1372
47. Endres M. Statins and stroke. J Cereb Blood Flow Metab 25 (2005) 1093-1110
48. Eskes C., Honegger P., Juillerat-Jeanneret L., et al. Microglial reaction induced by noncytotoxic methylmercury treatment leads to neuroprotection via interactions with astrocytes and IL-6 release. Glia 37 (2002) 43-52
49. Fujimura M., Morita-Fujimura Y., Murakami K., et al. Cytosolic redistribution of cytochrome c after transient focal cerebral ischemia in rats. J Cereb Blood Flow Metab 18 (1998) 1239-1247
50. Furlan A., Higashida R., Wechsler L., et al. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism. JAMA 282 (1999) 2003-2011
51. Gage F.H. Mammalian neural stem cells. Science 287 (2000) 1433-1438
52. Garthwaite G., Hajos F., and Garthwaite J. Ionic requirements for neurotoxic effects of excitatory amino acid analogues in rat cerebellar slices. Neuroscience 18 (1986) 437-447
53. Gill R., Foster A.C., and Woodruff G.N. Systemic administration of MK-801 protects against ischemia-induced hippocampal neurodegeneration in the gerbil. J Neurosci 7 (1987) 3343-3349
54. 2+ influx in hippocampal CA1 neurons of gerbil. J Neurosci 17 (1997) 6179-6188
55. Green A.R., Ashwood T., Odergren T., et al. Nitrones as neuroprotective agents in cerebral ischemia, with particular reference to NXY-059. Pharmacol Ther 100 (2003) 195-214
56. Greisenegger S., Mullner M., Tentschert S., et al. Effect of pretreatment with statins on the severity of acute ischemic cerebrovascular events. J Neurol Sci 221 (2004) 5-10
57. Grotta J., Clark W., Coull B., et al. Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial. Stroke 26 (1995) 602-605
58. Gunter T.E., and Pfeiffer D.R. Mechanisms by which mitochondria transport calcium. Am J Physiol 258 (1990) C755-C786
59. Hachimi-Idrissi S., and Huyghens L. Resuscitative mild hypothermia as a protective tool in brain damage: is there evidence?. Eur J Emerg Med 11 (2004) 335-342
60. Hacke W., Albers G., Al Rawi Y., et al. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 36 (2005) 66-73
61. Haley Jr. E.C., Lyden P.D., Johnston K.C., et al. A pilot dose-escalation safety study of tenecteplase in acute ischemic stroke. Stroke 36 (2005) 607-612
62. Hata R., Maeda K., Hermann D., et al. Dynamics of regional brain metabolism and gene expression after middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab 20 (2000) 306-315
63. Hill M.D., Rowley H.A., Adler F., et al. Selection of acute ischemic stroke patients for intra-arterial thrombolysis with pro-urokinase by using ASPECTS. Stroke 34 (2003) 1925-1931
64. Hollmann M., and Heinemann S. Cloned glutamate receptors. Annu Rev Neurosci 17 (1994) 31-108
65. Horn J., de Haan R.J., Vermeulen M., et al. Nimodipine in animal model experiments of focal cerebral ischemia: a systematic review. Stroke 32 (2001) 2433-2438
66. Hoyte L., Kaur J., and Buchan A.M. Lost in translation: taking neuroprotection from animal models to clinical trials. Exp Neurol 188 (2004) 200-204
67. Hypothermia After Cardiac Arrest Study Group. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 346 (2002) 549-556
68. Iijima T., Mishima T., Akagawa K., et al. Mitochondrial hyperpolarization after transient oxygen-glucose deprivation and subsequent apoptosis in cultured rat hippocampal neurons. Brain Res 993 (2003) 140-145
69. Imai H., Masayasu H., Dewar D., et al. Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke 32 (2001) 2149-2154
70. Jelkmann W. Biology of erythropoietin. Clin Investig 72 (1994) S3-S10
71. Jones W.H.S. Hippocrates. 472 edn. (1923), Heinemann, London
72. Kaur J., Zhao Z., Klein G.M., et al. The neurotoxicity of tissue plasminogen activator. J Cereb Blood Flow Metab 24 (2004) 945-963
73. Kennedy J., Quan H., Buchan A.M., et al. Statins are associated with better outcomes after carotid endarterectomy in symptomatic patients. Stroke 36 (2005) 2072-2076
74. Keynes R.G., and Garthwaite J. Nitric oxide and its role in ischaemic brain injury. Curr Mol Med 4 (2004) 179-191
75. Kumagai R., Oki C., Muramatsu Y., et al. Pitavastatin, a 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-coA) reductase inhibitor, reduces hippocampal damage after transient cerebral ischemia in gerbils. J Neural Transm 111 (2004) 1103-1120
76. Kuroda S., Tsuchidate R., Smith M.L., et al. Neuroprotective effects of a novel nitrone, NXY-059, after transient focal cerebral ischemia in the rat. J Cereb Blood Flow Metab 19 (1999) 778-787
77. Laufs U., Gertz K., Huang P., et al. Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke 31 (2000) 2442-2449
78. Lees K.R., Sharma A.K., Barer D., et al. Tolerability and pharmacokinetics of the nitrone NXY-059 in patients with acute stroke. Stroke 32 (2001) 675-680
79. Lees K.R., Hankey G.J., and Hacke W. Design of future acute-stroke treatment trials. Lancet Neurol 2 (2003) 54-61
80. Lees K.R., Zivin J.A., Ashwood T., et al. NXY-059 for acute ischemic stroke. N Engl J Med 354 (2006) 588-600
81. Le Peillet E., Arvin B., Moncada C., et al. The non-NMDA antagonists, NBQX and GYKI 52466, protect against cortical and striatal cell loss following transient global ischaemia in the rat. Brain Res 571 (1992) 115-120
82. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 79 (1999) 1431-1568
83. Lucas D.R., and Newhouse J.P. The toxic effect of sodium L-glutamate on the inner layers of the retina. AMA Arch Ophthalmol 58 (1957) 193-201
84. Mayer M.L., and Westbrook G.L. The physiology of excitatory amino acids in the vertebrate central nervous system. Prog Neurobiol 28 (1987) 197-276
85. Mao Y., Yang G.Y., Zhou L.F., et al. Focal cerebral ischemia in the mouse: description of a model and effects of permanent and temporary occlusion. Brain Res Mol Brain Res 63 (1999) 366-370
86. Marshall J.W., Cummings R.M., Bowes L.J., et al. Functional and histological evidence for the protective effect of NXY-059 in a primate model of stroke when given 4 hours after occlusion. Stroke 34 (2003) 2228-2233
87. 2+ exchanger in reperfusion-induced delayed cell death of cultured rat astrocytes. Eur J Neurosci 8 (1996) 951-958
88. 2+ exchanger, attenuates reperfusion injury in the in vitro and in vivo cerebral ischemic models. J Pharmacol Exp Ther 298 (2001) 249-256
89. McDonald J.W., Althomsons S.P., Hyrc K.L., et al. Oligodendrocytes from forebrain are highly vulnerable to AMPA/kainate receptor-mediated excitotoxicity. Nat Med 4 (1998) 291-297
90. Monaghan D.T., and Cotman C.W. Distribution of N-methyl-D-aspartate-sensitive L-[3H]glutamate-binding sites in rat brain. J Neurosci 5 (1985) 2909-2919
91. Nakatomi H., Kuriu T., Okabe S., et al. Regeneration of hippocampal pyramidal neurons after ischemic brain injury by recruitment of endogenous neural progenitors. Cell 110 (2002) 429-441
92. National Institute of Neurological Disorders and Stroke. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group. N Engl J Med 333 (1995) 1581-1587
93. 2+ and the stimulation of a nonlysosomal proteolytic system. J Biol Chem 261 (1986) 14628-14635
94. Olney J.W. Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate. Science 164 (1969) 719-721
95. Ouyang Y.B., and Giffard R.G. Cellular neuroprotective mechanisms in cerebral ischemia: Bcl-2 family proteins and protection of mitochondrial function. Cell Calcium 36 (2004) 303-311
96. Ouyang Y.B., Tan Y., Comb M., et al. Survival- and death-promoting events after transient cerebral ischemia: phosphorylation of Akt, release of cytochrome C and Activation of caspase-like proteases. J Cereb Blood Flow Metab 19 (1999) 1126-1135
97. Papadakis M., and Buchan A.M. NXY-059: brain or vessel protection. Stroke 37 (2006) 2189-2190
98. Peeling J., Del Bigio M.R., Corbett D., et al. Efficacy of disodium 4-[(tert-butylimino)methyl]benzene-1,3-disulfonate N-oxide (NXY-059), a free radical trapping agent, in a rat model of hemorrhagic stroke. Neuropharmacology 40 (2001) 433-439
99. Pond B.B., Galeffi F., Ahrens R., et al. Chloride transport inhibitors influence recovery from oxygen-glucose deprivation-induced cellular injury in adult hippocampus. Neuropharmacology 47 (2004) 253-262
100. Prospective Studies Collaboration. Cholesterol, diastolic blood pressure, and stroke: 13,000 strokes in 450,000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet 346 (1995) 1647-1653
101. Pulsinelli W.A., and Buchan A.M. The four-vessel occlusion rat model: method for complete occlusion of vertebral arteries and control of collateral circulation. Stroke 19 (1988) 913-914
102. Pulsinelli W.A., Brierley J.B., and Plum F. Temporal profile of neuronal damage in a model of transient forebrain ischemia. Ann Neurol 11 (1982) 491-498
103. Relton J.K., and Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 29 (1992) 243-246
104. Retz K.C., and Coyle J.T. The differential effects of excitatory amino acids on uptake of 45CaCl2 by slices from mouse striatum. Neuropharmacology 23 (1984) 89-94
105. Rod M.R., and Auer R.N. Pre- and post-ischemic administration of dizocilpine (MK-801) reduces cerebral necrosis in the rat. Can J Neurol Sci 16 (1989) 340-344
106. Rothman S.M. Synaptic activity mediates death of hypoxic neurons. Science 220 (1983) 536-537
107. Rytter A., Cronberg T., Asztely F., et al. Mouse hippocampal organotypic tissue cultures exposed to in vitro ischemia show selective and delayed CA1 damage that is aggravated by glucose. J Cereb Blood Flow Metab 23 (2003) 23-33
108. Rytter A., Cardoso C.M., Johansson P., et al. The temperature dependence and involvement of mitochondria permeability transition and caspase activation in damage to organotypic hippocampal slices following in vitro ischemia. J Neurochem 95 (2005) 1108-1117
109. Sadamoto Y., Abe Y., Higuchi K., et al. Retroperitoneal Castleman's disease of the hyaline vascular type presenting arborizing calcification. Intern Med 37 (1998) 691-693
110. Schmidt W., and Reymann K.G. Proliferating cells differentiate into neurons in the hippocampal CA1 region of gerbils after global cerebral ischemia. Neurosci Lett 334 (2002) 153-156
111. Schwartz G.G., and Olsson A.G. The case for intensive statin therapy after acute coronary syndromes. Am J Cardiol 96 (2005) 45F-53F
112. Sharp F.R., Liu J., and Bernabeu R. Neurogenesis following brain ischemia. Brain Res Dev Brain Res 134 (2002) 23-30
113. Sheardown M.J., Nielsen E.O., Hansen A.J., et al. 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247 (1990) 571-574
114. Shi Y. A structural view of mitochondria-mediated apoptosis. Nat Struct Biol 8 (2001) 394-401
115. Shuaib A., Lees K.R., Lyden P., et al. NXY-059 for the treatment of acute ischemic stroke. N Engl J Med 357 (2007) 562-571
116. Simon R.P., Swan J.H., Griffiths T., et al. Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226 (1984) 850-852
117. Siren A.L., and Ehrenreich H. Erythropoietin-a novel concept for neuroprotection. Eur Arch Psychiatry Clin Neurosci 251 (2001) 179-184
118. Sironi L., Cimino M., Guerrini U., et al. Treatment with statins after induction of focal ischemia in rats reduces the extent of brain damage. Arterioscler Thromb Vasc Biol 23 (2003) 322-327
119. Smith S.E., and Meldrum B.S. Cerebroprotective effect of a non-N-methyl-D-aspartate antagonist, GYKI 52466, after focal ischemia in the rat. Stroke 23 (1992) 861-864
120. Stroke Therapy Academic Industry Roundtable. Recommendations for standards regarding preclinical neuroprotective and restorative drug development. Stroke 30 (1999) 2752-2758
121. Stroke Therapy Academic Industry Roundtable. Recommendations for clinical trial evaluation of acute stroke therapies. Stroke 32 (2001) 1598-1606
122. Swan J.H., and Meldrum B.S. Protection by NMDA antagonists against selective cell loss following transient ischaemia. J Cereb Blood Flow Metab 10 (1990) 343-351
123. Sydserff S.G., Borelli A.R., Green A.R., et al. Effect of NXY-059 on infarct volume after transient or permanent middle cerebral artery occlusion in the rat; studies on dose, plasma concentration and therapeutic time window. Br J Pharmacol 135 (2002) 103-112
124. Takasawa K., Kitagawa K., Yagita Y., et al. Increased proliferation of neural progenitor cells but reduced survival of newborn cells in the contralateral hippocampus after focal cerebral ischemia in rats. J Cereb Blood Flow Metab 22 (2002) 299-307
125. Takuma K., Baba A., and Matsuda T. Astrocyte apoptosis: implications for neuroprotection. Prog Neurobiol 72 (2004) 111-127
126. 2+ chelators reduce early excitotoxic and ischemic neuronal injury in vitro and in vivo. Neuron 11 (1993) 221-235
127. Wang X., Tsuji K., Lee S.R., et al. Mechanisms of hemorrhagic transformation after tissue plasminogen activator reperfusion therapy for ischemic stroke. Stroke 35 (2004) 2726-2730
128. Wang L., Zhang Z., Wang Y., et al. Treatment of stroke with erythropoietin enhances neurogenesis and angiogenesis and improves neurological function in rats. Stroke 35 (2004) 1732-1737
129. Xue D., Huang Z.G., Barnes K., et al. Delayed treatment with AMPA, but not NMDA, antagonists reduces neocortical infarction. J Cereb Blood Flow Metab 14 (1994) 251-261
130. Yoshimoto T., Kristian T., Hu B., et al. Effect of NXY-059 on secondary mitochondrial dysfunction after transient focal ischemia; comparison with cyclosporin A. Brain Res 932 (2002) 99-109